Identification of Novel Prognostic Biomarkers That are Associated with Immune Microenvironment Based on GABA-Related Molecular Subtypes in Gastric Cancer

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. 2021;71:209–249. doi:10.3322/caac.21660
   Google Scholar
• Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144:1941–1953. doi:10.1002/ijc.31937
   PubMed Web of Science ®Google Scholar
• Song M, Rabkin CS, Camargo MC. Gastric cancer: an evolving disease. Curr Treat Options Gastroenterol. 2018;16:561–569. doi:10.1007/s11938-018-0203-1
   PubMedGoogle Scholar
• Maharjan U, Kauppila JH. Survival trends in gastric cancer patients between 1987 and 2016: a population-based cohort study in Finland. Gastric Cancer. 2022;25:989–1001. doi:10.1007/s10120-022-01326-5
   PubMed Web of Science ®Google Scholar
• Song Z, Wu Y, Yang J, Yang D, Fang X. Progress in the treatment of advanced gastric cancer. Tumour Biol. 2017;39:1010428317714626. doi:10.1177/1010428317714626
   Google Scholar
• Yoon H, Kim N. Diagnosis and management of high risk group for gastric cancer. Gut Liver. 2015;9:5–17. doi:10.5009/gnl14118
   PubMed Web of Science ®Google Scholar
• Shao S, Yang X, Zhang YN, et al. Oncolytic virotherapy in peritoneal metastasis gastric cancer: the challenges and achievements. Front Mol Biosci. 2022;9:835300. doi:10.3389/fmolb.2022.835300
   PubMed Web of Science ®Google Scholar
• Yao X, Ajani JA, Song S. Molecular biology and immunology of gastric cancer peritoneal metastasis. Transl Gastroenterol Hepatol. 2020;5:57. doi:10.21037/tgh.2020.02.08
   PubMed Web of Science ®Google Scholar
• Sasako M, Sano T, Yamamoto S, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359:453–462. doi:10.1056/NEJMoa0707035
   PubMed Web of Science ®Google Scholar
• Gajcy K, Lochyński S, Librowski T. A role of GABA analogues in the treatment of neurological diseases. Curr Med Chem. 2010;17:2338–2347. doi:10.2174/092986710791698549
   PubMed Web of Science ®Google Scholar
• Cherubini E, Di Cristo G, Avoli M. Dysregulation of GABAergic signaling in neurodevelomental disorders: targeting cation-chloride co-transporters to re-establish a proper E/I balance. Front Cell Neurosci. 2021;15:813441. doi:10.3389/fncel.2021.813441
   PubMed Web of Science ®Google Scholar
• Yuan H, Low CM, Moody OA, Jenkins A, Traynelis SF. Ionotropic GABA and glutamate receptor mutations and human neurologic diseases. Mol Pharmacol. 2015;88:203–217. doi:10.1124/mol.115.097998
   PubMed Web of Science ®Google Scholar
• Fontes MAP, Vaz GC, Cardoso TZD, et al. GABA-containing liposomes: neuroscience applications and translational perspectives for targeting neurological diseases. Nanomedicine. 2018;14:781–788. doi:10.1016/j.nano.2017.12.007
   PubMed Web of Science ®Google Scholar
• Watanabe M, Maemura K, Oki K, Shiraishi N, Shibayama Y, Katsu K. Gamma-aminobutyric acid (GABA) and cell proliferation: focus on cancer cells. Histol Histopathol. 2006;21:1135–1141. doi:10.14670/HH-21.1135
   PubMed Web of Science ®Google Scholar
• Huang D, Wang Y, Thompson JW, et al. Cancer-cell-derived GABA promotes β-catenin-mediated tumour growth and immunosuppression. Nat Cell Biol. 2022;24:230–241. doi:10.1038/s41556-021-00820-9
   PubMed Web of Science ®Google Scholar
• Solorzano SR, Imaz-Rosshandler I, Camacho-Arroyo I, et al. GABA promotes gastrin-releasing peptide secretion in NE/NE-like cells: contribution to prostate cancer progression. Sci Rep. 2018;8:10272. doi:10.1038/s41598-018-28538-z
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang R, Zheng Y, et al. Expression of gamma-aminobutyric acid receptors on neoplastic growth and prediction of prognosis in non-small cell lung cancer. J Transl Med. 2013;11:102. doi:10.1186/1479-5876-11-102
   PubMed Web of Science ®Google Scholar
• Dahn ML, Walsh HR, Dean CA, et al. Metabolite profiling reveals a connection between aldehyde dehydrogenase 1A3 and GABA metabolism in breast cancer metastasis. Metabolomics. 2022;18:9. doi:10.1007/s11306-021-01864-6
   PubMed Web of Science ®Google Scholar
• Thaker PH, Yokoi K, Jennings NB, et al. Inhibition of experimental colon cancer metastasis by the GABA-receptor agonist nembutal. Cancer Biol Ther. 2005;4:753–758. doi:10.4161/cbt.4.7.1827
   PubMed Web of Science ®Google Scholar
• Zhang D, Li X, Yao Z, Wei C, Ning N, Li J. GABAergic signaling facilitates breast cancer metastasis by promoting ERK1/2-dependent phosphorylation. Cancer Lett. 2014;348:100–108. doi:10.1016/j.canlet.2014.03.006
   PubMed Web of Science ®Google Scholar
• Fu J, Lin J, Zeng X, Li G, Wei Y, Xian L. GABRP is a promising prognostic biomarker and associated with immune cell infiltration in lung squamous cell carcinoma. Pharmgenomics Pers Med. 2023;16:357–371. doi:10.2147/PGPM.S403868
   PubMed Web of Science ®Google Scholar
• Yang L, Zhu J, Wang L, He L, Gong Y, Luo Q. A novel risk score model based on gamma-aminobutyric acid signature predicts the survival prognosis of patients with breast cancer. Front Oncol. 2023;13:1108823. doi:10.3389/fonc.2023.1108823
   PubMed Web of Science ®Google Scholar
• Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14:7. doi:10.1186/1471-2105-14-7
   PubMed Web of Science ®Google Scholar
• Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol. 2018;1711:243–259.
   PubMedGoogle Scholar
• Becht E, Giraldo NA, Lacroix L, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17:218. doi:10.1186/s13059-016-1070-5
   PubMed Web of Science ®Google Scholar
• Li T, Fan J, Wang B, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77:e108–e110. doi:10.1158/0008-5472.CAN-17-0307
   PubMed Web of Science ®Google Scholar
• Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9:559. doi:10.1186/1471-2105-9-559
   PubMed Web of Science ®Google Scholar
• Tang J, Kong D, Cui Q, et al. Prognostic genes of breast cancer identified by gene co-expression network analysis. Front Oncol. 2018;8:374. doi:10.3389/fonc.2018.00374
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Morris JH, Cook H, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2017;45:D362–d368. doi:10.1093/nar/gkw937
   PubMed Web of Science ®Google Scholar
• Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8:S11. doi:10.1186/1752-0509-8-S4-S11
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98–w102. doi:10.1093/nar/gkx247
   PubMed Web of Science ®Google Scholar
• Tan Z. Recent advances in the surgical treatment of advanced gastric cancer: a review. Med Sci Monit. 2019;25:3537–3541. doi:10.12659/MSM.916475
   PubMed Web of Science ®Google Scholar
• Johnston FM, Beckman M. Updates on management of gastric cancer. Curr Oncol Rep. 2019;21:67.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA. 2016;66:115–132. doi:10.3322/caac.21338
   Google Scholar
• Jiang SH, Hu LP, Wang X, Li J, Zhang ZG. Neurotransmitters: emerging targets in cancer. Oncogene. 2020;39:503–515. doi:10.1038/s41388-019-1006-0
   PubMed Web of Science ®Google Scholar
• Schuller H, Majidi M, Alwadei H. The GABA-B receptor (GABA-BR) is a novel drug target for the treatment and prevention of pancreatic cancer. Cancer Res. 2007;67:1.
   PubMedGoogle Scholar
• Maemura K, Shiraishi N, Sakagami K, et al. Proliferative effects of gamma-aminobutyric acid on the gastric cancer cell line are associated with extracellular signal-regulated kinase 1/2 activation. J Gastroenterol Hepatol. 2009;24:688–696. doi:10.1111/j.1440-1746.2008.05687.x
   PubMed Web of Science ®Google Scholar
• Lee HJ, Song IC, Yun HJ, Jo DY, Kim S. CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targeting. World J Gastroenterol. 2014;20:1681–1693. doi:10.3748/wjg.v20.i7.1681
   PubMed Web of Science ®Google Scholar
• Zavros Y, Merchant JL. The immune microenvironment in gastric adenocarcinoma. Nat Rev Gastroenterol Hepatol. 2022;19:451–467.
   PubMed Web of Science ®Google Scholar
• Li F, Sun Y, Huang J, Xu W, Liu J, Yuan Z. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis. Cancer Med. 2019;8:7330–7344. doi:10.1002/cam4.2596
   PubMed Web of Science ®Google Scholar
• Eum HH, Kwon M, Ryu D, et al. Tumor-promoting macrophages prevail in malignant ascites of advanced gastric cancer. Exp Mol Med. 2020;52:1976–1988.
   PubMed Web of Science ®Google Scholar
• Li Q, Zhang D, He W, et al. CD8(+) T cells located in tertiary lymphoid structures are associated with improved prognosis in patients with gastric cancer. Oncol Lett. 2020;20:2655–2664. doi:10.3892/ol.2020.11828
   PubMed Web of Science ®Google Scholar
• Qu J, Yang ZQ, Zhang Y, et al. Common variants of ATP1A3 but not ATP1A2 are associated with Chinese genetic generalized epilepsies. J Neurol Sci. 2015;354:56–62.
   PubMed Web of Science ®Google Scholar
• Bogdanov A, Moiseenko F, Dubina M. Abnormal expression of ATP1A1 and ATP1A2 in breast cancer. F1000Research. 2017;6:10. doi:10.12688/f1000research.10481.1
   PubMedGoogle Scholar
• Tan Z, Fu S, Feng R, et al. Identification of potential biomarkers for progression and prognosis of bladder cancer by comprehensive bioinformatics analysis. J Oncol. 2022;2022:1802706. doi:10.1155/2022/1802706
   PubMedGoogle Scholar
• Zhang B, Zhu Z, Zhang X, Li F, Ding A. Inhibition of the proliferation, invasion, migration, and epithelial-mesenchymal transition of prostate cancer cells through the action of ATP1A2 on the TGF-β/Smad pathway. Transl Androl Urol. 2022;11:53–66.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wei X, Bai G, et al. Identification of three potential prognostic genes in platinum-resistant ovarian cancer via integrated bioinformatics analysis. Cancer Manag Res. 2021;13:8629–8646. doi:10.2147/CMAR.S336672
   PubMed Web of Science ®Google Scholar
• Khan M, Lin J, Wang B, Chen C, Huang Z. A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma. Front Immunol. 2022;13:968165.
   PubMed Web of Science ®Google Scholar
• Ishimoto T, Sawayama H, Sugihara H, Baba H. Interaction between gastric cancer stem cells and the tumor microenvironment. J Gastroenterol. 2014;49:1111–1120.
   PubMed Web of Science ®Google Scholar
• Zhu X, Xie X, Zhao Q, Zhang L, Li C, Zhao D. Potential prognostic value and mechanism of stromal-immune signature in tumor microenvironment for stomach adenocarcinoma. Biomed Res Int. 2020;2020:4673153.
   PubMed Web of Science ®Google Scholar
• Zhang H, Li R, Cao Y, et al. Poor clinical outcomes and immunoevasive contexture in intratumoral IL-10-producing macrophages enriched gastric cancer patients. Ann Surg. 2022;275:e626–e635. doi:10.1097/SLA.0000000000004037
   PubMed Web of Science ®Google Scholar
• Yano H, Kinuta M, Tateishi H, et al. Mast cell infiltration around gastric cancer cells correlates with tumor angiogenesis and metastasis. Gastric Cancer. 1999;2:26–32.
   PubMedGoogle Scholar
• Yu K, Gu Y, Zhang P, et al. Intratumoral PD-1(+)CD8(+) T cells associate poor clinical outcomes and adjuvant chemotherapeutic benefit in gastric cancer. Br J Cancer. 2022;127:1709–1717. doi:10.1038/s41416-022-01939-8
   PubMed Web of Science ®Google Scholar
• Liu X, Yu H, Yan C, et al. Plasmacytoid dendritic cells and ICOS(+) Regulatory T cells predict poor prognosis in gastric cancer: a pilot study. J Cancer. 2019;10:6711–6715.
   PubMed Web of Science ®Google Scholar